MaxLinear Sees Q3 Sales $210.000M-$220.000M vs $173.837M Est

Benzinga Newsdesk www.benzinga.com Positive 84.4%

Neg 0% Neu 0% Pos 84.4%

MaxLinear (NASDAQ:MXL) sees Q3 sales of $210.000 million-$220.000 million vs $173.837 million analyst estimate.

Comments

No comments yet. Be the first!